Ranbaxy Pays $2.3M To Settle Generic Safety Suit
The Oregon Department of Justice announced on Tuesday a $2.3 million settlement with India-based drugmaker Ranbaxy Laboratories Ltd. and two affiliated American companies stemming from allegations Ranbaxy sold generic prescription drugs...To view the full article, register now.
Already a subscriber? Click here to view full article